Skip to main content
Equibles

STOREBRAND ASSET MANAGEMENT AS

Position in VTRS — Viatris Inc

CIK 1685676 LYSAKER, Q8
Back to VTRS Full portfolio

Position in VTRS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10,891,425
+$1,074,357 QoQ
Shares Held
685,858
-5.6% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#117
of 1,021 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STOREBRAND ASSET MANAGEMENT AS holds $68,472,125 across 4 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (15.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 91,690 $49,680,392
2 VTRS
Viatris Inc
This page 		685,858 $10,891,425
3 ZTS
Zoetis Inc.
 93,356 $6,708,562
4 NBIX
Neurocrine Biosciences Inc
 7,071 $1,191,746

All Filings in VTRS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,891,425 685,858
2026-03-31 $9,817,068 726,652
2025-12-31 $10,032,919 805,857
2025-09-30 $9,849,866 994,936
2025-06-30 $9,286,557 1,039,928
2025-03-31 $14,111,933 1,620,199
2024-12-31 $19,830,210 1,592,788
2024-09-30 $21,466,425 1,848,960
2024-06-30 $19,814,213 1,863,990
2024-03-31 $22,464,715 1,881,467
2023-12-31 $21,305,479 1,967,265
2023-09-30 $18,223,242 1,848,199
2023-06-30 $18,264,038 1,830,064
2023-03-31 $15,413,077 1,602,191
2022-12-31 $16,433,478 1,476,503
2022-09-30 $9,432,372 1,107,086
2022-06-30 $11,689,063 1,116,434
2022-03-31 $9,189,400 844,614
2021-12-31 $9,828,760 726,442
2021-09-30 $10,963,955 809,148
2021-06-30 $9,061,517 634,116
2021-03-31 $8,918,727 638,420
2020-12-31 $11,304,680 603,238

Report a Problem

Category
Description
Email (optional, for follow-up)